Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Small Cell Lung Carcinoma 2Non-squamous Non-small Cell Lung Cancer 2Breast Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Sertoli-Leydig Cell Tumor 1Ovarian gynandroblastoma 1Ovarian Neoplasms 1Non-squamous NSCLC 1Lung Neoplasms 1Locally Advanced Cervical Carcinoma 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Granulosa cell tumor of the ovary 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1Endometrial Clear Cell Adenocarcinoma 1Brain Neoplasms 1Anus Neoplasms 1Anal Canal Carcinoma 1Advanced Esophagus Cancer 1

Interventions

Taxes 1Radiotherapy 1Radiation 1Platinum 1Paclitaxel 1Cisplatin 1Carboplatin 1Brachytherapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Endometrial Clear Cell Adenocarcinoma × Platinum × Clear all
NCT00942357 2021-10-19

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

GOG Foundation

Phase 3 Unknown
813 enrolled 14 charts
Gynecologic

Endometrial Clear Cell Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡